The DOI matches its Crossref record; 213 of the 215 references it cites were found in a registry or an index.
Kynurenines in the mammalian brain: when physiology meets pathology
Open accessAbstract
The essential amino acid tryptophan is not only a precursor of serotonin but is also degraded to several other neuroactive compounds, including kynurenic acid, 3-hydroxykynurenine and quinolinic acid. The synthesis of these metabolites is regulated by an enzymatic cascade, known as the kynurenine pathway, that is tightly controlled by the immune system. Dysregulation of this pathway, resulting in hyper-or hypofunction of active metabolites, is associated with neurodegenerative and other neurological disorders, as well as with psychiatric diseases such as depression and schizophrenia. With recently developed pharmacological agents, it is now possible to restore metabolic equilibrium and envisage novel therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Kynurenine and its metabolites, including kynurenic acid and quinolinic acid, have been implicated in mental health (Cervenka et al., 2017;Schwarcz et al., 2012).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Schwarcz et al., 2012
In the citing paper
“Mounting evidence suggests that the GM modulates the tryptophan and kynurenine pathways and is a humoral route through which the GM may influence cognition at the level of the CNS (206–210).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [209]
In the citing paper
“Other metabolites of tryptophan metabolism, kynurenines, have also been implicated in a range of neurobiological functions (392).”
From Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health (2021) · cites this paper as [392]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898
Mammalian nicotinic acetylcholine receptors: from structure to function
Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009) · Physiological Reviews · doi:10.1152/physrev.00015.2008 · Cited by 1,724
Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain
Simon, R. P., Swan, J. H., Griffiths, T., & Meldrum, B. S. (1984) · Science · doi:10.1126/science.6093256 · Cited by 1,682
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Anis, N. A., Berry, S. C., Burton, N. R., & Lodge, D. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb11031.x · Cited by 1,399
Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R. M., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,269
Self-citationLesion of striatal neurons with kainic acid provides a model for Huntington's chorea
Coyle, J. T., & Schwarcz, R. M. (1976) · Nature · doi:10.1038/263244a0 · Cited by 1,255
Self-citationSubanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia
Lahti, A., Koffel, B., Laporte, D., & Tamminga, C. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00131-i · Cited by 965
Flagged first, then by citations
2 of the 215 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 901–1,000 of 1,002
Reducing brain kynurenic acid synthesis precludes kynurenine‐induced sleep disturbances
Rentschler, K. M., Milosavljevic, S., Baratta, A. M., Wright, C. J., Piroli, M. V., Tentor, Z., Valafar, H., O’Reilly, C., & Pocivavsek, A. (2023) · Journal of Sleep Research · doi:10.1111/jsr.14038 · Cited by 16
“…of KYNA elevation on sleep behaviour provides compelling evidence for the role of KYNA, rather than the alternate arm of the KP that produces the metabolites 3-hydroxykynurenine, 3-hydroxyanthranilic acid and quinolinic acid (Schwarcz et al., 2012), in modulating changes in sleep physiology.”
Alzheimer’s and metabolism wed with IDO1
Johnson, L. A., & Macauley, S. L. (2024) · Science · doi:10.1126/science.adr5836 · Cited by 12
Heme-based dioxygenases: Structure, function and dynamics
Geeraerts, Z., Ishigami, I., Gao, Y., & Yeh, S. (2024) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2024.112707 · Cited by 13
Kupjetz, M., Chirino, T. Y. W., Joisten, N., & Zimmer, P. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149415 · Cited by 14
“However, there is some evidence that especially frontal, hippocampal, thalamic, striatal, and pallidal neurons are susceptible to QA-mediated damage (Guillemin, 2012; Schwarcz and K ¨ ohler, 1983; Schwarcz et al., 2012).”
Jellen, L. C., Galvis, M. L. E., Sha, Q., Isaguirre, C., Johnson, A., Madaj, Z. B., Lewis, M. M., Sheldon, R. D., Kong, L., Huang, X., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00949-6 · Cited by 13
“TheKP(Fig.1)catabolizesover90% 22 ofdietarytryptophan(TRP)in the brain and periphery fi rst into L -kynurenine (KYN), then into several branches of neuroactive and immunoregulatory metabolites (kynur-enines) that can have neuroprotective or neurotoxic properties 23 .”
Kynurenines and Mitochondrial Disturbances in Multiple Sclerosis
Pukoli, D., & Vécsei, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115098 · Cited by 17
“Excitotoxicity: QUIN acts as an NMDA receptor agonist, directly triggering excito-toxicity in neurons and oligodendrocytes, a process known as endogenous excitotoxicity [14].”
Formisano, S., Hornig, M., Yaddanapudi, K., Vasishtha, M., Parsons, L., Briese, T., Lipkin, W., & Williams, B. L. (2017) · Journal of Virology · doi:10.1128/jvi.00673-17 · Cited by 13
Cross-talk in NAD+ metabolism: insights from Saccharomyces cerevisiae
Raj, C. J. T., & Lin, S.-J. (2019) · Current Genetics · doi:10.1007/s00294-019-00972-0 · Cited by 13
Wright, C. J., Rentschler, K. M., Wagner, N. T. J., Lewis, A. M., Beggiato, S., & Pocivavsek, A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.734984 · Cited by 13
Transport of Xanthurenic Acid by Rat/Human Organic Anion Transporters OAT1 and OAT3
Uwai, Y., & HONJO, E. (2013) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.130178 · Cited by 13
Dorta, E., Aspée, A., Pino, E., González, L., Lissi, E. A., & López‐Alarcón, C. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.082 · Cited by 13
Nicholson, J. R., & Sommer, B. (2018) · Brain and Neuroscience Advances · doi:10.1177/2398212818804030 · Cited by 14
“Other examples of systems involved in anxiety with the potential for measurement of blood or CSFbased biomarkers include the kynurenine system (Schwarcz et al., 2012), serine racemase system (Basu et al., 2009) and neuropeptides such as orexin (Flores et al., 2015).”
BackgroundRios‐Avila, L., Coats, B. S., Ralat, M. A., Chi, Y., Midttun, Ø., Ueland, P. M., Stacpoole, P. W., & Gregory, J. F. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.113159 · Cited by 13
Savino, R., Carotenuto, M., Polito, A. N., Di Noia, S., Albenzio, M., Scarinci, A., Ambrosi, A., Sessa, F., Tartaglia, N., & Messina, G. (2020) · doi:10.20944/preprints202007.0425.v1 · Cited by 54
Gut–brain axis in health and brain disease
Olasunkanmi, O. I., Zheng, L., & Zheng, P. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003920 · Cited by 12
“[169,170] Notably, KMO inhibition has been shown to significantly reduce extracellular glutamate concentrations in the basal ganglia–but not in the cortex or hippocampus–highlighting the region-specific role of KMO in modulating glutamatergic neurotrans-mission.”
Fang, C., Hayashi, S., Du, X., Cai, X., Deng, B., Zheng, H., Ishido, S., Tsutsui, H., & Sheng, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-86659-4 · Cited by 12
Torre, D. L., Dalile, B., de Loor, H., Oudenhove, L. V., & Verbeke, K. (2021) · Stress · doi:10.1080/10253890.2021.1959546 · Cited by 12
“KYN can be further metabolized along different pathways, into either kynurenic acid (KYNA) or quinolinic acid (QUINO) and ultimately into oxidized nicotinamide-adenine-dinucleotideþ (Schwarcz et al., 2012), which induce opposite effects.”
Boros, F. A., Maszlag-Török, R., Szűcs, M., Annus, Á., Klivènyi, P., & Vécsei, L. (2021) · Biomedicines · doi:10.3390/biomedicines9101441 · Cited by 13
“In addition to the unambiguous results indicating enhanced Trp metabolism, recently the KP attracted further interest in relation to stroke due to the realization of the importance of inflammatory processes in the pathomechanism of CNS disorders [2,17].”
BackgroundElevated Kynurenine Levels in Patients with Primary Sjögren’s Syndrome
Apaydın, H., Bicer, C. K., Yurt, E. F., Serdar, M. A., Doğan, İ., & Erten, Ş. (2022) · Laboratory Medicine · doi:10.1093/labmed/lmac084 · Cited by 14
Aarsland, T. I. M., Instanes, J. T., Posserud, M.-B. R., Ulvik, A., Keßler, U., & Haavik, J. (2022) · Pharmaceuticals · doi:10.3390/ph15111439 · Cited by 13
“The concentration of IDO and TDO is substantially lower in the brain than in other tissues, and most of the local metabolism seems to be based on Kyn [24].”
BackgroundStress and Kynurenine-Inflammation Pathway in Major Depressive Disorder
Mingoti, M. E. D., Bertollo, A. G., de Oliveira, T., & Ignácio, Z. M. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_8 · Cited by 12
Balter, L. J. T., Li, X., Schwieler, L., Erhardt, S., Axelsson, J., Olsson, M. J., Lasselin, J., & Lekander, M. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106110 · Cited by 13
“, (Raison et al., 2010; Schwarcz et al., 2012) however the kynurenine pathway timeline in the periphery does not necessarily coincide with the kynurenine pathway timeline in the brain (Kindler et al.”
BackgroundPotential CSF biomarkers of postpartum depression following delivery via caesarian section
Sheng, Z., Liu, Q., Lin, R., Zhao, Y., Liu, W., Xu, Z., & Liu, Z. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.09.021 · Cited by 12
Lu, J., Zhang, Y., Qian, H. R., Zhou, H., & Zong, Y. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2023.2262741 · Cited by 12
“Proinflammatory cytokines, such as il-1β, il-6 and iNF-γ cause iDO activation in the brain [16, 17, 18]. the expression of iDO and level of KYN in the brain of rats with hepatic encephalopathy were increased, and rats showed a progressive decline in memory formation. treatment with iDO inhibitor…”
Bakker, L., Ramakers, I. H. G. B., Eussen, S. J. P. M., Choe, K., van den Hove, D., Kenis, G., Rutten, B. P. F., van Oostenbrugge, R. J., Staals, J., Ulvik, A., et al. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.120819 · Cited by 14
“Activated microglia and macrophages are producing a spectrum of kynurenines, including quinolinic acid (QA), which is an N -methyl- D -aspartate (NMDA) receptor agonist and a pro-oxidant [15].”
Tryptophan Prevents the Development of Non-Alcoholic Fatty Liver Disease
Yanko, R. V., Levashov, M. I., Chaka, O. G., Nosar, V. I., Khasabov, S. G., & Khasabova, I. A. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s444278 · Cited by 12
“15 High-calorie diet (HCD) has been shown to disrupt tryptophan metabolism, which contributes to inflammation, increased excitatory neurotransmission 16–19 and leads to impaired mitochondrial function and fat accumulation in the liver.”
BackgroundVanaveski, T., Narvik, J., Innos, J., Philips, M., Ottas, A., Plaas, M., Haring, L., Zilmer, M., & Vasar, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00399 · Cited by 12
Liu, Y., Hu, X., Zheng, W. L., Zhang, L., Gui, L., Liang, G., Zhang, Y., Hu, L., Li, X., Zhong, Y., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1011608 · Cited by 12
“, serotonin, N-acetylserotonin, and melatonin (Schwarcz et al., 2012; Oxenkrug, 2013).”
Yamamoto, S., Ooshima, Y., Nakata, M., Yano, T., Nishimura, N., Nishigaki, R., Satomi, Y., Matsumoto, H., Matsumoto, Y., & Takeyama, M. (2015) · Transgenic Research · doi:10.1007/s11248-015-9909-1 · Cited by 12
White, K. A., Hutton, S. R., Weimer, J. M., & Sheridan, P. A. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.06.007 · Cited by 12
Human serine racemase is allosterically modulated by NADH and reduced nicotinamide derivatives
Bruno, S., Marchesani, F., Dellafiora, L., Margiotta, M., Faggiano, S., Campanini, B., & Mozzarelli, A. (2016) · Biochemical Journal · doi:10.1042/bcj20160566 · Cited by 12
Immune markers of social cognitive bias in schizophrenia
Dunne, P. W., Roberts, D. L., Quinones, M. P., Velligan, D. I., Paredes, M., & Walss-Bass, C. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.02.030 · Cited by 12
GeRNet: a gene regulatory network tool
Dussaut, J. S., Gallo, C. A., Cravero, F., Martínez, M. J., Carballido, J. A., & Ponzoni, I. (2017) · Biosystems · doi:10.1016/j.biosystems.2017.08.006 · Cited by 12
Navrotskaya, V., Wnorowski, A., Turski, W. A., & Oxenkrug, G. F. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9891-5 · Cited by 12
Tao, W., Tian, J., Xu, T., Xu, S. L., Xie, H. Q., Zhou, Z., Guo, Z., Fu, H., Yin, X., Chen, Y., et al. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.11.086 · Cited by 12
Serum xanthurenic acid levels: Reduced in subjects at ultra high risk for psychosis
Curto, M., Lionetto, L., Fazio, F., Corigliano, V., Comparelli, A., Ferracuti, S., Simmaco, M., Nicoletti, F., & Baldessarini, R. J. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.02.020 · Cited by 12
Experimental hypothyroidism raises brain kynurenic acid – Novel aspect of thyroid dysfunction
Tomczyk, T., & Urbańska, E. M. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173363 · Cited by 12
Plasma Anthranilic Acid and Leptin Levels Predict HAM-D Scores in Depressed Women
Steiner, J. H., Dobrowolny, H., Guest, P. C., Bernstein, H., Fuchs, D., Roeser, J., D, P. S. M., & Oxenkrug, G. F. (2021) · International Journal of Tryptophan Research · doi:10.1177/11786469211016474 · Cited by 12
Therapeutic Strategies for Huntington’s Disease
Mrzljak, L., & Muñoz-Sanjuán, I. (2013) · Current topics in behavioral neurosciences · doi:10.1007/7854_2013_250 · Cited by 12
Physiology of Astroglia: Channels, Receptors, Transporters, Ion Signaling and Gliotransmission
Verkhratsky, A., & Parpura, V. (2015) · Colloquium Series on Neuroglia in Biology and Medicine From Physiology to Disease · doi:10.4199/c00123ed1v01y201501ngl004 · Cited by 12
Possible changes of New-Generation inflammation markers with occupational lead exposure
Si̇pahi̇, H., Girgin, G., Palabıyık, Ş. S., Tutkun, E., Yilmaz, O. H., & Baydar, T. (2017) · Journal of Occupational Health · doi:10.1539/joh.16-0273-oa · Cited by 12
Lee, K., Jung, K., Cho, J., Lee, S., Kim, H. S., Shim, J. H., Lee, S. K., Kim, M., & Chu, K. (2017) · Experimental Neurobiology · doi:10.5607/en.2017.26.3.132 · Cited by 12
Ouyang, W., Sun, G., & Hsu, M. (2019) · Aggression and Violent Behavior · doi:10.1016/j.avb.2019.101347 · Cited by 12
Jia, K., Pan, S., Wu, W., Sun, Y., & Zhang, Q. (2024) · Journal of Ginseng Research · doi:10.1016/j.jgr.2024.12.002 · Cited by 11
“Experimental and clinical data show that elevated Kyn levels are associated with depressive behavior [10,14].”
Benevenuto, D., Saxena, K., Fries, G. R., Valvassori, S. S., Kahlon, R., Saxena, J. E., Kurian, S. R., Zeni, C., Kazimi, I. F., Scaini, G., et al. (2020) · Bipolar Disorders · doi:10.1111/bdi.13027 · Cited by 11
Zhou, G., Tang, Y.-Y., Zuo, J.-X., Tao, Y., Tang, J.-P., Zhang, P., Zou, W., & Tang, X. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115137 · Cited by 11
Gaweł, K. (2024) · Cells · doi:10.3390/cells13050453 · Cited by 11
“QUIN is eventually converted to nicotine adenine dinucleotide (NAD) [8,15].”
BackgroundUnveiling the hidden pathways: Exploring astrocytes as a key target for depression therapy
Liu, Y., Chen, L., Lin, L., Xu, C., Xiong, Y., Qiu, H., Li, X., Li, S., & Cao, H. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.04.003 · Cited by 12
Sex-specific associations of kynurenic acid with neopterin in Alzheimer’s disease
Knapskog, A., Edwin, T. H., Ueland, P. M., Ulvik, A., Fang, E. F., Eldholm, R. S., Halaas, N. B., Giil, L. M., Saltvedt, I. T., Watne, L. O., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01531-7 · Cited by 11
“Abbreviations: 3-HK 3-hydroxykynurenine, AA anthranilic acid, AD Alzheimer’s disease, CU cognitively unimpaired, KA kynurenic acid, Kyn kynurenine, Pic picolinic acid, Trp trypthophan, QA quinolinic acid [5, 12, 49], possibly modified by APOE ε4 genotype [50].”
BackgroundMelese, D. M., Aragaw, A., & Mekonen, W. (2024) · Epilepsia Open · doi:10.1002/epi4.13066 · Cited by 11
Dziewa, M., Złotek, M., Herbet, M., & Piątkowska‐Chmiel, I. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01514-0 · Cited by 11
Xu, Q., Liu, X., Heng, H., Wang, H., Chen, K., Chan, E. W., Yang, G., & Chen, S. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012979 · Cited by 11
“Dysregulation of Kyn and its downstream metabolites, which leads to an imbalance in Kyn metabolite levels in the brain, has been associated with neurodegenerative conditions and psychological disorders, including schizophrenia and depression [56].”
Abedrabbo, M., Kazemian, P., Connolly, C., & Leavitt, B. R. (2025) · Journal of Huntington s Disease · doi:10.1177/18796397251330144 · Cited by 12
“78 In contrast, the oxidative branch of the pathway resulting in the formation of 3HK and QUIN is predominantly active in microglia and is associated with oxidative damage due to interaction with iron (Fe II), 79 which promotes the generation of ROS and reactive nitrogen species.”
Promising Gastric Cancer Biomarkers—Focus on Tryptophan Metabolism via the Kynurenine Pathway
Ożga, K., Stepuch, P., Maciejewski, R., & Sadok, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083706 · Cited by 10
“ACMS is rapidly converted to quinolinic acid (QA) by the non-enzymatic reaction or to 2-aminomuconic semialdehyde (AMS) [17].”
Menni, A.-E., Theodorou, H., Tzikos, G., Theodorou, I. M., Semertzidou, E., Stelmach, V., Shrewsbury, A. D., Stavrou, G., & Kotzampassi, K. E. (2025) · Nutrients · doi:10.3390/nu17122022 · Cited by 13
“…positive results in other related parameters in this study [59]: an improvement in cognitive functions along with a decreased kynurenine concentration and an increase in 3-hydroxy-kynurenine to kynurenine ratio, which could be considered contributing factors to cognitive improvement [63,95].”
Li, J., Bai, J., Liu, G., Zhu, Z., & Cao, C. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12070247 · Cited by 12
“In contrast, individuals with a low KAT activity can activate alternative anti-inflammatory pathways through moderate-intensity continuous exercise (MICE) [52].”
Amaral, A. U., Seminotti, B., da Silva, J. C., de Oliveira, F. H., Ribeiro, R. T., Vargas, C. R., Leipnitz, G., Santamarı́a, A., Souza, D. O., & Wajner, M. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9848-0 · Cited by 11
Electrochemical Detection of Tryptophan Metabolites via Kynurenine Pathway by Using Nanocarbon Films
Kato, D., Kamata, T., & Sumimoto, M. (2021) · Electroanalysis · doi:10.1002/elan.202100241 · Cited by 11
Guan, X., Xu, J., Xiu, M., Li, X., Liu, H., & Wu, F. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13895 · Cited by 10
Seasonal Changes in Serum Metabolites in Multiple Sclerosis Relapse
Martynova, E. V., Хайбуллин, Т. И., Salafutdinov, I. I., Markelova, M., Laikov, A. V., Lopukhov, L. V., Liu, R., Sahay, K., Goyal, M., Baranwal, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043542 · Cited by 14
“We also demonstrated seasonal changes in serum level of L-Kynurenine and quinolinic acid, tryptophan metabolism products [82].”
BackgroundWartchow, K. M., Scaini, G., & Quevedo, J. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_9 · Cited by 12
Wang, Y., Fang, X., Wang, G., Tang, W., Liu, S., Yang, Y., Chen, J., Ling, Y., Zhou, C., Zhang, X., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.06.016 · Cited by 11
Andreou, D., Söderman, E., Axelsson, T., Sedvall, G. C., Terenius, L. Y., Agartz, I., & Jönsson, E. G. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.06.023 · Cited by 11
Animal Models for Depression Associated with HIV-1 Infection
Barreto, I. C. G., Viegas, P. D. B., Ziff, E. B., & Konkiewitz, E. C. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9518-9 · Cited by 11
New prospects for antipsychotic treatment - the role of the kynurenine pathway
Karakuła‐Juchnowicz, H., Flis, M., Szymona, K., Kuczyńska, M., Stelmach, E., & Kowal-Popczak, A. (2014) · Psychiatria Polska · doi:10.12740/pp/25520 · Cited by 11
Douet, V., Tanizaki, N., Franke, A. A., Li, X., & Chang, L. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9668-7 · Cited by 11
Navrotskaya, V., & Oxenkrug, G. F. (2016) · Pharmacology Drug Development & Therapeutics · doi:10.15761/pddt.1000104 · Cited by 11
Chang, C.-H., Lane, H., Liu, C., Cheng, P.-C., Chen, S.-J., & Lin, C. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s223278 · Cited by 11
Curatolo, P., & Moavero, R. (2021) · Nutrients · doi:10.3390/nu13051631 · Cited by 6
“tive molecules, which act as antagonists of NMDA (N-methyl-D-aspartate) receptors [38].”
BackgroundEbokaiwe, A. P., Ushang, O. R., Chimezie, I. P., & Nvene, C. (2022) · Toxicology · doi:10.1016/j.tox.2022.153191 · Cited by 11
Langner, E., Lemieszek, M. K., Kwiecień, J. M., Rajtar, G., Rzeski, W., & Turski, W. A. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2009-7 · Cited by 11
Comprehensive behavioral analysis of indoleamine 2,3‐dioxygenase knockout mice
Hirata, N., Hattori, S., Shoji, H., Funakoshi, H., & Miyakawa, T. (2018) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12019 · Cited by 10
“2018;38:133–144. wileyonlinelibrary.com/journal/nppr | 133 3-hydroxykynurenie,3 kynurenic acid (KYNA),4–6 and quinolinic acid (QUIN).7,8 Generally, more than 95% of dietary, Trp is metabolized along the KP to produce neuroactive KYNA and QUIN, and only a small amount of it is converted to serotonin.9 Dysfunction of th…”
BackgroundInfluentialO’Reilly, K., O’Farrell, K., Midttun, Ø., Rakovets, Y., David‐Bercholz, J., & Harkin, A. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09976-x · Cited by 12
Groth, B., Huang, C.-C., & Lin, S.-J. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102410 · Cited by 11
“For instance, intermediates of de novo metabolism have been associated with both beneficial and adverse influences on neurological health (16, 46, 47) and have also been shown to interact with immune signaling (16, 46–49).”
Backgroundde la Cruz, G. P., de la Cruz, V. P., Cossio, J. Á. N., Cervantes, G. I. V., Salazar, A., Orozco‐Morales, M., & Pineda, B. (2023) · Pharmaceuticals · doi:10.3390/ph16030369 · Cited by 10
Cai, L., Xu, Z., Luo, H., He, Q., Diao, L., Gui, X., & Wei, L. (2023) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2023.109354 · Cited by 10
Li, F., Xie, L., Xiao, Q., Li, J., Zhong, H., Xu, X., Tu, J., & Luo, Q. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.176215 · Cited by 11
A comparative study on the antioxidant and antiglycation properties of different vitamin D forms
Pawlukianiec, C., Lauko, K. K., Michalak, D., Żendzian‐Piotrowska, M., Zalewska, A., & Maciejczyk, M. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117263 · Cited by 11
Peripheral tryptophan-kynurenine pathway dysfunction in first-episode schizophrenia
Li, M., Wu, Y., Xu, Y., Huang, X., Gao, K., Hu, N., Zhu, S., Wang, C., & Liang, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-86390-4 · Cited by 13
Gurow, K., Joshi, D. C., Gwasikoti, J., & Joshi, N. (2025) · Hormone and Metabolic Research · doi:10.1055/a-2536-1421 · Cited by 12
“There are numerous associations between changes in this system and disease [20].”
The anti-inflammation pharmacodynamics of lithium: Therapy of bipolar disorder
Zhou, Y., Zheng, W., Guo, F., Wu, S., & Zhong, C. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251326942 · Cited by 11
Cui, W., Su, F., Liu, S., Zhang, L., Yang, H., Rasoamananto, I., Lavitra, T., & Sun, L. (2025) · Aquaculture · doi:10.1016/j.aquaculture.2025.742512 · Cited by 10
Choe, K., Bakker, L., van den Hove, D., Eussen, S. J. P. M., Kenis, G., Ramakers, I. H. G. B., Verhey, F. R. J., Rutten, B. P. F., & Köhler, S. (2025) · GeroScience · doi:10.1007/s11357-025-01636-3 · Cited by 12
“This suggests that during (neuro)inflammation, astrocytes may upregulate the production of KA to mitigate neurotoxicity [148].”
Kaluski-Kopatch, S., Stein, D., García-Venzor, A., Campos, A. M. F., Planque, M., Goldstein, B., Allende-Becerra, E. D., Smirnov, D., Zaretsky, A., Eremenko, E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67021-y · Cited by 12
“Nosigni fi cantchangeswereobservedintheexpressionlevels of Kynurenine aminotransferase ( Kyat ) family including Aadat , which predominantly express in the brain 60,61 , Got , Ccbl1 , and Ccbl2 (Fig.”
Ko, W. K. D., Li, Q., & Bézard, E. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.02.027 · Cited by 10
Myint, K., Jacobs, K. R., Myint, A.-M., Lam, S. K., Lim, Y. A. L., Boey, C. C. M., Hoe, S.-Z., & Guillemin, G. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.702301 · Cited by 10
Jao, J. K., Balmert, L. C., Sun, S., McComsey, G. A., Brown, T. T., Tien, P. C., Currier, J. S., Stein, J. H., Qiu, Y., LeRoith, D., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab663 · Cited by 11
Dey, S., Dubey, V., Dixit, A. B., Tripathi, M., Chandra, P. S., & Banerjee, J. (2022) · Cells · doi:10.3390/cells11223560 · Cited by 10
“The increased IDO activity is an Indication of an abnormal tryptophan–kynurenine pathway and an imbalance between kynurenic acid and quinolinic acid, documented in various neurological disorders [3].”
BackgroundKretzschmar, G. C., Targa, A., Soares‐Lima, S. C., dos Santos, P. I., Rodrigues, L. S., Macedo, D. A., Pinto, L. F. R., Lima, M. M. S., & Boldt, A. B. W. (2022) · Genes · doi:10.3390/genes13122397 · Cited by 10
“Within the KP, KYN results from the tryptophan metabolism [52], and KYNU is one of the enzymes responsible for KYN and 3-hydroxykynurenine (3-HK) processing.”
The kynurenine pathway in traumatic brain injuries and concussion
Dehhaghi, M., Heng, B., & Guillemin, G. J. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1210453 · Cited by 10
“Among KP metabolites, KYNA and QUIN due to their polar properties and lack of transportation systems cannot cross the blood-brain barrier (BBB), while other KP metabolites cross the BBB through active transportation and passive diffusion (36, 37).”
BackgroundWen, T., Liu, X., Pang, T., Li, M., Jiao, G., Fan, X., Tang, J., Zhang, C., Wang, Z., Yue, X., et al. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s446336 · Cited by 11
“41,42 Thus, two metabolic hypotheses were predicted for CGGD treatment: (1) the level of kynurenine transported across the BBB was decreased, and(2) the level of tryptophan in the brain converted into kynurenine was decreased.”
BackgroundAnthranilic Acid, a GPR109A Agonist, and Schizophrenia
Oxenkrug, G. F., & Forester, B. P. (2024) · International Journal of Tryptophan Research · doi:10.1177/11786469241239125 · Cited by 13
Oxenkrug, G. F. (2015) · Springer eBooks · doi:10.1007/978-3-319-11870-3_13 · Cited by 10
Overview of the Kynurenine Pathway of Tryptophan Metabolism
Michelhaugh, S. K., Guastella, A. R., & Mittal, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-11870-3_1 · Cited by 10
Narvik, J., Vanaveski, T., Innos, J., Philips, M., Ottas, A., Haring, L., Zilmer, M., & Vasar, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-21752-9 · Cited by 12
Leszczyńska, A., Misztal, T., Marcińczyk, N., Kaminski, T. W., Kramkowski, K., Chabielska, E., & Pawlak, D. (2019) · Advances in Medical Sciences · doi:10.1016/j.advms.2019.05.003 · Cited by 10
The significance of physical activity in the prevention of depressive disorders
Saran, T., Mazur, A., & Łukasiewicz, J. (2020) · Psychiatria Polska · doi:10.12740/pp/onlinefirst/118054 · Cited by 11
“At the same time, tryptophan is degraded by kynurenine transformations, which generates a number of intermediate metabolites with high biological activity with regard to glutamatergic receptors, such as kynurenine, quinolinic acid and kynurenic acid [26].”
Intestinal Bacteria Encapsulated by Biomaterials Enhance Immunotherapy
Liu, Y., Li, Z., Wu, Y., Jing, X., Li, L., & Fang, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.620170 · Cited by 10
Multisensory Integration in Caenorhabditis elegans in Comparison to Mammals
Yu, Y. V., Xue, W., & Chen, Y. (2022) · Brain Sciences · doi:10.3390/brainsci12101368 · Cited by 9
Role of Inflammation in Psychiatric Disease
Raison, C. L., Rook, G. A. W., Miller, A. H., & Begay, T. K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-398270-4.00026-4 · Cited by 10
Metadata
- Authors
- Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q.
- Affiliations
- University of Maryland, Baltimore (US)
- The Ohio State University (US)
- University of California, San Francisco (US)
- Corresponding author
- Schwarcz, Robert
- Venue
- Nature Reviews Neuroscience
- Published
- 2012-06-08
- Volume
- 13
- Issue
- 7
- Pages
- 465-477
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- PMC
- PMC3681811
- OpenAlex
- W2060050678
- Cited by
- 1,530
- References
- 215
- Citations by year
- 2026: 157 · 2025: 137 · 2024: 124 · 2023: 98 · 2022: 118 · 2021: 145 · 2020: 132 · 2019: 95 · 2018: 83 · 2017: 96 · 2016: 98 · 2015: 105 · 2014: 64 · 2013: 63 · 2012: 13
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R01MH083729)
- National Institute of Neurological Disorders and Stroke (R01NS057715)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- kynurenine pathway, tryptophan metabolism, kynurenic acid, 3-hydroxykynurenine, quinolinic acid, neuroactive metabolites, neurodegenerative diseases, depression, schizophrenia, therapeutic targeting
- MeSH terms
- Animals, Brain, Humans, Kynurenine, Nervous System Diseases, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review